Rheumatoid Arthritis News

    Skip to content
    • Home
    • Treatments
      • Tofacitinib (Xeljanz)
    • Experimental Treatments
      • Piclidenoson
      • Kevzara (Sarilumab)
      • Baricitinib (Olumiant)
    • About Us
    • Contact Us
    •
      June 12, 2017August 24, 2022

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      Diplomat Pharmacy has begun filling prescriptions for Kevzara (sarilumab) for patients with moderate to severe rheumatoid arthritis (RA). The announcement comes after the U.S. Food and Drug ... Read more
    • June 7, 2017June 7, 2017

      Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      Active rheumatoid arthritis (RA) patients whose response to methotrexate (MTX) therapy was insufficient showed improvement when MTX was combined with filgotinib, an investigational JAK–1 inhibitor, according ... Read more
    • June 5, 2017June 5, 2017

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      The European Medicines Agency (EMA) has accepted a marketing authorization application from generic pharmaceuticals developer Sandoz for the review of biosimilars for AbbVie’s Humira (adalimumab) and Janssen’s Remicade (infliximab), ... Read more
    • June 2, 2017June 2, 2017

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      Results of a recent study showed that biological therapy regimens, such as Enbrel (etanercept), Humira (adalimumab), ‎Remicade (infliximab), ‎Simponi (golimumab), or ‎Cimzia (certolizumab), are less cost-effective ... Read more
    • May 23, 2017May 23, 2017

      Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs

      Kevzara (sarilumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with moderate to severely active rheumatoid arthritis ... Read more
    Obesity Causes Rheumatoid Arthritis to Develop Earlier, Delays Treatment Effect in Mice
    November 9, 2016November 9, 2016

    Obesity Causes Rheumatoid Arthritis to Develop Earlier, Delays Treatment Effect in Mice

    News
    New research in mice shows that obesity causes rheumatoid arthritis (RA) to develop earlier, and may play a role in slowing the effect of anti-TNF-alpha antibody drugs, the current standard medication ... Read more
    Baricitinib Enhances RA Patients’ Outcomes in Phase 3 Trial
    November 7, 2016November 7, 2016

    Baricitinib Enhances RA Patients’ Outcomes in Phase 3 Trial

    News
    Patients with rheumatoid arthritis (RA) and inadequate responses to biological disease-modifying antirheumatic drugs (bDMARDs) show a positive response to treatment with baricitinib (LY3009104), with the therapy improving several patient-reported outcomes, ... Read more
    Biosimilar of Humira for Rheumatoid Arthritis Passes Critical Phase 3 Trial
    November 4, 2016November 4, 2016

    Biosimilar of Humira for Rheumatoid Arthritis Passes Critical Phase 3 Trial

    News, rheumatoid arthritis
    Boehringer Ingelheim‘s BI 695501 has been deemed effectively equivalent to Humira (adalimumab) in patients with active rheumatoid arthritis (RA), according to the results of a crucial Phase 3 clinical trial comparing the two ... Read more
    Cimzia AutoClicks Prefilled Pen for RA, Other Types of Arthritis, Now Available in UK
    October 26, 2016October 26, 2016

    Cimzia AutoClicks Prefilled Pen for RA, Other Types of Arthritis, Now Available in UK

    News
    The Cimzia (certolizumab pegol) AutoClicks Prefilled Pen was just made available in the United Kingdom through the National Health System (NHS), announced UCB, a company focused on neurology and immunology disorders. Designed ... Read more
    Pfizer to Begin Shipping Inflectra for RA, Other Illnesses to US Wholesalers in November
    October 24, 2016October 24, 2016

    Pfizer to Begin Shipping Inflectra for RA, Other Illnesses to US Wholesalers in November

    News
    Pfizer recently announced that its Inflectra (infliximab-dyyb) for injection will be shipped to U.S. wholesalers in late November. Inflectra is a biosimilar of Remicade (infliximab), and is the first FDA approved biosimilar monoclonal antibody ... Read more
    Ablynx Concludes Phase 2 Trials of RA Therapy, Losing Partner AbbVie in the Process
    October 21, 2016October 21, 2016

    Ablynx Concludes Phase 2 Trials of RA Therapy, Losing Partner AbbVie in the Process

    News
    Ablynx is about to wrap up its Phase 2 trials of vobarilizumab (ALX-0061) for patients with rheumatoid arthritis, and is discussing a move toward Phase 3 studies with U.S. and European ... Read more
    Wheat Protein May Be Linked to Inflammation in Rheumatoid Arthritis, Study Says
    October 19, 2016October 19, 2016

    Wheat Protein May Be Linked to Inflammation in Rheumatoid Arthritis, Study Says

    News
    Inflammation in people with rheumatoid arthritis may be promoted by a group of proteins, called amylase-trypsin inhibitors (ATIs), that are commonly found in wheat, researchers reported. ATIs might also play a role in ... Read more
    Early Rheumatoid Arthritis, Bone Loss Linked to Autoantibodies
    October 17, 2016October 17, 2016

    Early Rheumatoid Arthritis, Bone Loss Linked to Autoantibodies

    News
    The presence of certain autoantibodies in rheumatoid arthritis (RA) is linked to bone loss in patients with early disease, suggesting that bone remodeling in rheumatoid arthritis is directly connected to autoimmunity. ... Read more
    $1.1M Grant Awarded to Study Effects of Aging on New Blood Vessels; May Help Guide Future RA Therapies
    October 14, 2016October 14, 2016

    $1.1M Grant Awarded to Study Effects of Aging on New Blood Vessels; May Help Guide Future RA Therapies

    News
    A Tulane University research team received a National Institutes of Health (NIH) grant of $1.1 million to study the effects of aging on the growth of new blood vessels, a ... Read more
    Feinstein Institute CEO Honored with Frederik Bang Award for Work into Immune System
    October 10, 2016October 10, 2016

    Feinstein Institute CEO Honored with Frederik Bang Award for Work into Immune System

    News
    Kevin J. Tracey, MD, chief executive officer and president of the Feinstein Institute for Medical Research, has been awarded the Frederik B. Bang Award — the highest honor given by the International Endotoxin and ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another RA update.

    * indicates required
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • Diplomat selling Kevzara

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      June 12, 2017

    • Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      June 7, 2017

    • Truxima, a biosimilar of rituximab

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      June 5, 2017

    • triple therapy

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      June 2, 2017

    • About Us
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Rheumatoid Arthritis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.